Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes.

BMJ case reports - 11 Jul 2012

Besser Rachel E J, Jones Jackie, McDonald Timothy J, Smith Rebecca, Shepherd Maggie H, Hattersley Andrew T

Abstract excerpt

The authors report an adolescent who was found to have diabetes on routine blood testing. The initial diagnosis was type 2 diabetes because she was obese, did not have type 1 diabetes antibodies and both parents had diabetes. Highly sensitive C-reactive protein (hsCRP) was low in the proband and her father (≤0.1 mg/l) indicating that type 2 diabetes was unlikely, and that hepatocyte nuclear factor 1-α-maturity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Diagnosis, Differential

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Glycated Hemoglobin

Share to Pedigree

Source

Open in PubMed Open full text

Identifiers

PMID: 22787179
DOI: 10.1136/bcr.01.2012.5612
PMCID: PMC3416990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes.PMID 22787179Read ↗

Update on clinical screening of maturity-onset diabetes of the young (MODY)Semantic proximity Read ↗

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.Semantic proximity Read ↗

Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.Semantic proximity Read ↗

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.Semantic proximity Read ↗

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.Semantic proximity Read ↗

Treatment implications of a delayed diagnosis of maturity-onset diabetes of the young.Semantic proximity Read ↗

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.Semantic proximity Read ↗

Characteristics of maturity onset diabetes of the young in a large diabetes center.Semantic proximity Read ↗

When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?Semantic proximity Read ↗

Two siblings with a rare type of maturity-onset diabetes of the young (MODY).Semantic proximity Read ↗

Diagnosis of maturity-onset diabetes of the young in the pediatric diabetes clinic.Semantic proximity Read ↗

Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.